SEC Form 4 research
| Issuer | Bambusa Therapeutics, Inc. |
|---|---|
| Tickers | BBTX |
| Reporting owners | 14 |
| Officers and directors | 2 |
| Last public filing | 2026-11-03 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-03 | 2026-11-02 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., Shah Rajeev M. | P | 164,891 | $16 | Not reported |
| 2026-11-03 | 2026-11-02 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., Shah Rajeev M. | P | 2,335,109 | $16 | Not reported |
| 2026-11-03 | 2026-10-30 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., Shah Rajeev M. | P | 263,911 | $14.92 | Not reported |
| 2026-11-03 | 2026-10-30 | Kolchinsky Peter, RA CAPITAL MANAGEMENT, L.P., RA Capital Healthcare Fund LP, RA Capital Nexus Fund III, L.P., Shah Rajeev M. | P | 189,909 | $14.23 | Not reported |
| 2026-11-02 | 2026-11-02 | Salvia Investment GmbH | P | 375,000 | $16 | Not reported |
| 2026-11-02 | 2026-11-02 | Jeggle Helmut Wolfgang | P | 375,000 | $16 | Not reported |
| 2026-11-02 | 2026-10-29 | Xu Shanshan | A | 758,204 | $0 | Not reported |
| 2026-11-02 | 2026-10-29 | Xu Shanshan | A | 379,102 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.